Coeptis Therapeutics Holdings, Inc. (BHSE)

Evaluation: Based on all recent filings, financial statements, and news.

See full evaluation
Ask a question about Coeptis Therapeutics Holdings, Inc. (BHSE)
Company Performance

Current Price

as of Oct 18, 2024

$0.21

P/E Ratio

N/A

Market Cap

$8.37M

Description

Coeptis Therapeutics Holdings, Inc. is a biopharmaceutical company, which engages in developing innovative cell therapy platforms for cancer that can disrupt conventional treatment paradigms and improve patient outcomes. The firm's products include CD38-GEAR-NK, CD38-Diagnostic and GEAR-NK Product. The company was founded in 2017 and is headquartered in Wexford, PA.

Metrics

Overview

  • HQWexford, PA
  • SectorHealth Technology
  • IndustryBiotechnology
  • TickerBHSE
  • Price$0.2094+5.23%

Trading Information

  • Market Cap$8.37M
  • Float71.11%
  • Average Daily Volume (1m)373,483
  • Average Daily Volume (3m)258,723
  • EPS-$0.51

Company

  • RevenueN/A
  • Rev Growth (1yr)N/A
  • Net Income-$3.04M
  • Gross MarginN/A
  • EBITDA MarginN/A
  • EBITDA-$2.58M
  • EV$11.22M
  • EV/RevenueN/A
  • P/EN/A
  • P/SN/A
  • P/B1.17
Documents